Covered recipient · General Payments record
ROBERT A CROWDER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$245.20
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $204.20 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $54.92 | 3 |
| GlaxoSmithKline, LLC. | $40.64 | 2 |
| Abbott Laboratories | $35.77 | 2 |
| Novo Nordisk AS | $24.67 | 1 |
| Exact Sciences Corporation | $17.68 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.21 | 1 |
| PFIZER INC. | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.18 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125113256 | CMS |
| Abbott Laboratories | $20.59 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125113258 | CMS |
| Exact Sciences Corporation | $17.68 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114624455 | CMS |
| GlaxoSmithKline, LLC. | $16.22 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116133350 | CMS |
| GlaxoSmithKline, LLC. | $24.42 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116645330 | CMS |
| Lilly USA, LLC | $20.38 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367634 | CMS |
| Lilly USA, LLC | $17.16 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355118 | CMS |
| Lilly USA, LLC | $17.38 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135335874 | CMS |
| Novo Nordisk Inc | $24.67 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097548992 | CMS |
| PFIZER INC. | $14.31 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033431 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.21 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151052563 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.